Clinical trials: Feeding Intolerance
- Condition Feeding Intolerance
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Feeding Disorder
Study in Unsettled Infants Experiencing Feeding Intolerance
Multinational, multicenter, clinical trial. To evaluate the effect of an experimental formula on GI symptoms and associated behaviors in unsettled infants with parent-reported feeding intolerance
- Trial name
- NCT02021058
- Testing
- Experimental Formula, Standard control formula
- Where
- 6 sites in Hong Kong, Philippines and 2 more
- Volunteers
- 259 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)
Gastrointestinal Diseases, Feeding Intolerance
Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediatric Population
The objective of this study is to determine the safe use and tolerance of a peptide-based formula in children with gastrointestinal dysfunction and/or feeding intolerance.
- Trial name
- NCT01191112
- Testing
- Peptide based enteral formula
- Where
- Canada
- Volunteers
- 27 people
- Sponsor
- Abbott Nutrition
Colic
Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance
The present pilot study is aimed to obtain preliminary data on the effect of three ascending oral dose levels of nepadutant on the relief of symptoms associated with feeding intolerance.
- Trial name
- NCT01532518
- Testing
- Nepadutant
- Where
- 5 sites in United States
- Volunteers
- 27 people
- Sponsor
- Menarini Group
Infant, Premature, Infant, Newborn
A Study of Cisapride in Premature Infants With Feeding Problems
The purpose of this study is to evaluate the effectiveness of Cisapride in improving feeding problems in premature newborn infants.
- Trial name
- NCT01281566
- Testing
- Cisapride
- Volunteers
- 8 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Feeding Intolerance
Feeding Intolerance in Formula-Fed Infants
This is a non-randomized, single-group, multi-center, two phased study to evaluate formula intolerance.
- Trial name
- NCT02028156
- Testing
- Partially Hydrolyzed Infant Formula
- Where
- 3 sites in China
- Volunteers
- 3 people, healthy volunteers welcome
- Sponsor
- Abbott Nutrition
Feeding Intolerance
Tolerance of an Extensively Hydrolyzed Protein Infant Formula Versus a Premature Infant Formula
To evaluate the use of a hypoallergenic infant formula containing an extensively hydrolyzed protein source for routine nutrition.
- Trial name
- NCT01987154
- Testing
- Marketed cow milk-based premature infant formula, Marketed extensively hydrolyzed casein infant formula
- Where
- Italy
- Volunteers
- 61 people
- Sponsor
- Mead Johnson Nutrition
Children Requiring Amino Acid-based Formula Tube Feeding, Enteral Feeding Intolerance
Retrospective Review of Amino Acid Formula Use at a Children's Center
This is a retrospective review of data documented in medical records.
- Trial name
- NCT03497091
- Testing
- Enteral Formula
- Where
- United States
- Volunteers
- 23 people
- Sponsor
- Société des Produits Nestlé (SPN)
Malnutrition, Infant, Enteral Feeding Intolerance
Efficacy and Safety of Numeta G13%E Compared to Compounded Parenteral Nutrition in Preterm Neonates
Preterm (PT, born before 37 weeks of gestation) birth complications are the leading causes of death among children aged under 5 years globally, with nearly one million infant deaths reported in 2013.
- Trial name
- NCT06894446
- Testing
- Numeta G13%E, Compounded Parenteral Nutrition (cPN) solution
- Volunteers
- healthy volunteers welcome
- Sponsor
- Baxter Healthcare Corporation
Enteral Feeding Intolerance, Tube Feeding
Review of Enteral Formulas in Children
Retrospective review of nutrition enteral formula data documented in medical records.
- Conditions
- Enteral Feeding Intolerance, Tube Feeding, Nutrition Disorder, Child
- Trial name
- NCT04247269
- Testing
- Enteral Tube Feeding
- Where
- United States
- Sponsor
- Société des Produits Nestlé (SPN)